T1	Participants 54 113	young adults with childhood-onset growth hormone deficiency
T2	Participants 127 243	Growth hormone (GH) treatment in young adults with childhood-onset GH deficiency has beneficial effects on bone mass
T3	Participants 317 422	GH treatment, with endosteal expansion and increased cortical thickness leading to improved bone strength
T4	Participants 437 522	In young adults with childhood-onset growth hormone deficiency (CO GHD), GH treatment
T5	Participants 651 724	the study was to evaluate the influence of GH on cortical bone dimensions
T6	Participants 734 797	Patients (n = 160; mean age, 21.2 years; 63% males) with CO GHD
